Key Takeaways
- • Daryl Tol is stepping down as CEO of HATCo, the holding company General Catalyst uses to control Summa Health, according to Axios.
- • The departure marks the third high-level exit from HATCo's top job, following two earlier veteran hospital executives who also left the role.
- • The leadership turnover raises questions about the direction of General Catalyst's health care strategy, per Axios.
Summary
Daryl Tol is stepping down as chief executive of HATCo, the holding company through which General Catalyst controls Summa Health, Axios reported. The report describes the exit as another high-level leadership departure at the vehicle, which General Catalyst established to hold its stake in the Akron-based health system.
Axios noted that two previous veteran hospital executives have already exited HATCo's top job. Those repeated changes at the CEO level are the basis for the publication's assessment that the turnover raises questions about the direction of General Catalyst's ambitious health care strategy.
The primary source does not disclose a named successor in the excerpt available for this summary, nor does it provide financial terms, performance figures, or a stated reason for Tol's departure. Readers seeking those details should consult the original Axios report.
Axios noted that two previous veteran hospital executives have already exited HATCo's top job. Those repeated changes at the CEO level are the basis for the publication's assessment that the turnover raises questions about the direction of General Catalyst's ambitious health care strategy.
The primary source does not disclose a named successor in the excerpt available for this summary, nor does it provide financial terms, performance figures, or a stated reason for Tol's departure. Readers seeking those details should consult the original Axios report.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.